Research map: Cardiomyocyte-Specific Inhibition of p53 Signaling as a Therapeutic Strategy for Arrhythmogenic Right Ventricular Cardiomyopathy Type 5

Back to the article

Papers in this map

  1. Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Is a Fully Penetrant, Lethal Arrhythmic Disorder Caused by a Missense Mutation in the TMEM43 Gene · Nancy D. Merner · 2008 · 515 citations · Cited by this paper
  2. Small Extracellular Vesicles From Cardiomyocytes Activate Microglia Aggravating HFpEF · 2026 · Related
  3. Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β · Laura Padrón-Barthe · 2019 · 93 citations · Cited by this paper
  4. Contractility Drives Cardiomyocyte Maturation and the Response to Nanopatterns · 2026 · Related
  5. Haploinsufficiency ofTmem43in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy · Leila Rouhi · 2020 · 53 citations · Cited by this paper
  6. Monocyte Dll4 Contributes to Systemic Inflammation in People Living With HIV · 2026 · Related
  7. Lipoproteins in Cardiovascular Disease: Building on Successes to Meet Future Challenges · 2026 · Related
  8. Epicardial Fat Drives Macrophage Response in Atrial Cardiomyopathy · 2026 · Related
  9. Inflammasome-Primed Neutrophils Aggravate Atherosclerosis in Cigarette Smoking · 2026 · Related
  10. Antibody E06 and the Role of Oxidized Phospholipids in Atherogenesis and Inflammation · 2026 · Related
  11. Glycine Receptor α2 Mediates Vasodilation via Endothelial eNOS Signaling · 2026 · Related
  12. Distinct Urinary Protein Signatures in Adolescent Blood Pressure Phenotypes · 2026 · Related
  13. Kidney-Vascular Metabolic Crosstalk: Altered Lipoproteins in CKD · 2026 · Related

Source: OpenAlex (CC0)